Inventor · disambiguated record
Guy Vergnault
Also filed as: VERGNAULT GUY
22 granted patents·16 pending applications·498 citations·filing 1997–2016
95Inventor score
Top patents by PatentIndex Score
38 records- 0194US6027748APharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorptionJAGOTEC AG·Filed 1998·Granted Feb 22, 2000·194 cites·15 claims
- 0292US6149940ATablet with controlled release of alfuzosine chlorhydrateSYNTHELABO·Filed 1997·Granted Nov 21, 2000·150 cites·23 claims
- 0391US8394407B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2012·Granted Mar 12, 2013·14 cites·19 claims
- 0487US8460706B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2011·Granted Jun 11, 2013·8 cites·25 claims
- 0585US9622980B2Controlled release compositionsJAGOTEC AG·Filed 2015·Granted Apr 18, 2017·5 cites·23 claims
- 0685US7927624B2Hydrophilic/lipophilic polymeric matrix dosage formulationJAGOTEC AG·Filed 2007·Granted Apr 19, 2011·5 cites·35 claims
- 0785US6221395B1Controlled release pharmaceutical tablets containing an active principle of low water solubilityJAGOTEC AG·Filed 1998·Granted Apr 24, 2001·76 cites·4 claims
- 0884US8168218B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2004·Granted May 1, 2012·16 cites·9 claims
- 0983US8309124B2Delayed release tablet with defined core geometryVERGNAULT GUY·Filed 2012·Granted Nov 13, 2012·5 cites·14 claims
- 1079US8303986B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2009·Granted Nov 6, 2012·2 cites·7 claims
- 1177US10076500B2Floating gastric retentive dosage formJAGOTEC AG·Filed 2016·Granted Sep 18, 2018·1 cites·26 claims
- 1276US9314430B2Floating gastric retentive dosage formGRENIER PASCAL·Filed 2011·Granted Apr 19, 2016·1 cites·15 claims
- 1375US9101544B2Controlled release nisoldipine compositionsGRENIER PASCAL·Filed 2007·Granted Aug 11, 2015·2 cites·24 claims
- 1474US8003690B2Topical nanoparticulate spironolactone formulationJAGOTEC AG·Filed 2002·Granted Aug 23, 2011·9 cites·20 claims
- 1573US9040085B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2014·Granted May 26, 2015·1 cites·11 claims
- 1673US7838028B2Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of sameJAGOTEC AG·Filed 2002·Granted Nov 23, 2010·8 cites·12 claims
- 1772US9186332B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2012·Granted Nov 17, 2015·1 cites·18 claims
- 1860US2008221174A1Controlled release nisoldipine compositionsJAGOTEC AG·Filed 2008·Application pending·0 cites
- 1958US9884021B2Delayed release tablet with defined core geometryJAGOTEC AG·Filed 2015·Granted Feb 6, 2018·0 cites·15 claims
- 2055US2005032876A1Pharmaceutical compositions comprising sumatriptan and metoclopramide, and methods of use thereofFiled 2004·Application pending·0 cites
- 2154US2008069886A1Spironolactone nanoparticles, compositions and methods related theretoJAGOTEC AG·Filed 2007·Application pending·0 cites
- 2254US2007148229A1Tablet with coloured coreJAGOTEC AG·Filed 2004·Application pending·0 cites
- 2350US2003180359A1Hydrophilic/ lipophilic polymeric matrix dosage formulationFiled 2001·Application pending·0 cites
- 2449US2014243296A1Organic CompoundsJAGOTEC AG·Filed 2012·Application pending·0 cites
- 2549US2010291209A1Organic compoundsVERGNAULT GUY·Filed 2008·Application pending·0 cites
- 2648US2010196475A1Controlled release tablet formulation containing magnesium aluminometasilicateGRENIER PASCAL·Filed 2008·Application pending·0 cites
- 2748US2010092557A1Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid AnalgesicVERGNAULT GUY·Filed 2007·Application pending·0 cites
- 2847US8927608B2Compositions comprising amphetamin and lisdexamfetamineVERGNAULT GUY·Filed 2011·Granted Jan 6, 2015·0 cites·21 claims
- 2947US8663693B2Nanoparticulate formulations of fenofibrateGRENIER PASCAL·Filed 2002·Granted Mar 4, 2014·0 cites·8 claims
- 3047US2014255499A1Method of Forming Fine Particles of a Drug SubstanceJAGOTEC AG·Filed 2012·Application pending·0 cites
- 3147US2010233259A1Dosage form of ropiniroleGRENIER PASCAL·Filed 2009·Application pending·0 cites
- 3246US8980363B2Method and apparatus for producing a centred compression coated tabletGRENIER PASCAL·Filed 2008·Granted Mar 17, 2015·0 cites·6 claims
- 3346US2004151776A1Novel compositionsFiled 2002·Application pending·0 cites
- 3444US8697755B2Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemiaVERGNAULT GUY·Filed 2010·Granted Apr 15, 2014·0 cites·8 claims
- 3543US2015133416A1Pharmaceutical Composition Comprising Abiraterone AcetateJAGOTEC AG·Filed 2013·Application pending·0 cites
- 3642US2012213910A1Tablets with Site- and Time- Controlled Gastrointestinal Release of Active IngredientSCHAEFFLER ACHIM·Filed 2012·Application pending·0 cites
- 3742US2009297601A1Dosage form time-lagged of drugs for the therapy of insomniaVERGNAULT GUY·Filed 2005·Application pending·0 cites
- 3837US2017319698A1Gastroretentive gel formulationsJAGOTEC AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guy Vergnault files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →